PolyPid (PYPD) Non Operating Income (2019 - 2025)
PolyPid's (PYPD) quarterly Non Operating Income came in at $24000.0 in Q4 2025, down 91.61% year-over-year from $286000.0 in Q4 2024, and down 95.39% quarter-over-quarter from $521000.0 in Q2 2025.
Powered by 
Analysis
PolyPid (PYPD) Non Operating Income (2019 - 2025) Analysis & Trends
PolyPid has disclosed Non Operating Income across 7 years of filings, most recently posting $24000.0 for Q4 2025.
- In Q4 2025, Non Operating Income fell 91.61% year-over-year to $24000.0; the TTM figure through Dec 2025 stood at $1.5 million (up 58.68% YoY), while the FY2025 annual figure was $685000.0, down 27.97% from the prior year.
- Non Operating Income came in at $24000.0 for Q4 2025 at PolyPid, down from $521000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $678000.0 in Q1 2025 to a low of $7000.0 in Q2 2023.
- Average Non Operating Income over 5 years is $250647.1, with a median of $255000.0 recorded in 2023.
- Year-over-year, Non Operating Income tumbled 97.51% in 2023 and jumped 2342.86% in 2024.
- Over 5 years, Non Operating Income stood at $152000.0 in 2021, then plunged by 34.21% to $100000.0 in 2022, then soared by 248.0% to $348000.0 in 2023, then slipped by 17.82% to $286000.0 in 2024, then tumbled by 91.61% to $24000.0 in 2025.
- Per Business Quant data, the three most recent Non Operating Income figures were $24000.0 in Q4 2025, $521000.0 in Q2 2025, and $678000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | -73.00 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 387.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 234.30 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | PolyPid | 85.52 Mn | 78.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 24,000.00 |
| Jun 30, 2025 | 521,000.00 |
| Mar 31, 2025 | 678,000.00 |
| Dec 31, 2024 | 286,000.00 |
| Sep 30, 2024 | 354,000.00 |
| Jun 30, 2024 | 171,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 348,000.00 |
| Sep 30, 2023 | 319,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 255,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 437,000.00 |
| Jun 30, 2022 | 281,000.00 |
| Mar 31, 2022 | 78,000.00 |
| Dec 31, 2021 | 152,000.00 |
| Mar 31, 2021 | 110,000.00 |
| Dec 31, 2020 | 339,000.00 |
| Dec 31, 2019 | 548,000.00 |